Connect with us

Health

Anti-infective therapy for infections caused by drug-resistant gram-negative pathogens now in Phase I study – Outbreak News Today – Outbreak News Today

By NewsDesk @infectiousdiseasenews Biopharmaceutical company, Qpex Biopharma, announced this week the initiation of a Phase…

Published

4 years ago

on

June 20, 2021

By

Noosa Online News Publisher

Article feature image

By NewsDesk @infectiousdiseasenews
Biopharmaceutical company, Qpex Biopharma, announced this week the initiation of a Phase 1 study of QPX9003, a next generation intravenous (IV)-administered synthetic polymyxin for infections caused by drug-resistant…

Click here to view the original article.

Related Topics:Australia Outbreak News Today

SARS, MERS, COVID-19 and Disease X? Another pandemic may still be ahead of us. But what could it be? – ABC News

Father of 8 was set to get 2nd vaccine dose, but contracted COVID-19 and died – wphm.net

Continue Reading

Advertisement

General24 hours ago

Diamonds defeat Proteas 64-53 in first netball Test in Bendigo

General24 hours ago

Mitch Marsh inspires Australia to three-wicket win over New Zealand in third T20I

General23 hours ago

Nothing to see here *wink wink*

General21 hours ago

Newcastle Jets defeat semi-professional Heidelberg United 3-1 to lift first Australia Cup

About Us	Contact Us

© 2025 Noosa Online News
Privacy Policy